Inventory

9 Months Ended

Sep. 30, 2023

Inventory Disclosure [Abstract]

Inventory

Inventory

Components of inventory, net of reserves, as of September 30, 2023 and December 31, 2022 are as follows (table in thousands):

	September 30, 2023		December 31, 2022
Inventory - Current Portion
Raw Materials	$	2,335	$	3,351
Work in Process	337		351
Finished Goods	2,814		2,112
Total Current Inventory	5,486		5,814
Inventory - Long Term (1)	178		1,276
Total Inventory	$	5,664	$	7,090

__________

1.Represents inventory related to Triferic raw materials. This Triferic inventory will be utilized for the Company's international partnerships. In September 2022, the Company discontinued its New Drug Applications ("NDAs") for Triferic (dialysate) and Triferic AVNU in the United States. During the three months ended September 30, 2023, the Company reserved $1.1 million of long-term inventory as a result of the termination of the Wanbang development effort.

As of September 30, 2023 and December 31, 2022, Rockwell had total current concentrate inventory aggregating $5.5 million and $5.8 million, respectively, against which Rockwell had reserved $25,000 at both September 30, 2023 and December 31, 2022.